American Century Companies’s Maravai LifeSciences MRVI Stock Holding History

American Century Companies’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-64,519	Closed	-$559K	–	2916
2024 Q1	$559K	Sell	64,519 -26,354	-29%	-$178K	﹤0.01%	2410
2023 Q4	$595K	Buy	90,873 +29,334	+48%	+$190K	﹤0.01%	2300
2023 Q3	$615K	Buy	61,539 +32,869	+115%	+$361K	﹤0.01%	2191
2023 Q2	$356K	Sell	28,670 -2,261,949	-99%	-$30.5M	﹤0.01%	2337
2023 Q1	$30.9M	Sell	2,290,619 -64,899	-3%	-$932K	0.02%	576
2022 Q4	$33.7M	Sell	2,355,518 -1,542,833	-40%	-$24.3M	0.03%	538
2022 Q3	$99.5M	Buy	3,898,351 +1,501,611	+63%	+$37.7M	0.09%	257
2022 Q2	$68.1M	Buy	+2,396,740	New	+$75.9M	0.06%	351

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies's MRVI Position: Q2 2024 in Review

American Century Companies sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 64,519 shares — an estimated $559K sold.

American Century Companies first reported a position in MRVI in Q2 2022 and held it in 8 quarters. The position peaked at $99.5M in Q3 2022. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

American Century Companies reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
American Century Companies sold 64,519 Maravai LifeSciences shares in Q2 2024, an estimated $559K.
American Century Companies first reported a position in Maravai LifeSciences in Q2 2022 and held it in 8 quarters.
American Century Companies's Maravai LifeSciences position peaked at $99.5M in Q3 2022.
206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on American Century Companies's 13F filing for Q2 2024, filed 7 Aug 2024.